Lv2
180 积分 2024-09-16 加入
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
1个月前
已完结
Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease
2个月前
已完结
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series
2个月前
已完结
Incidence and Risk Factors for Development of Acne (JAKne) in Patients with Inflammatory Bowel Disease Treated With Upadacitinib
2个月前
已关闭
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
2个月前
已完结
Systematic review with meta‐analysis: loss of response and requirement of ustekinumab dose escalation in inflammatory bowel diseases
10个月前
已完结
Pharmacogenomics and the Resulting Impact on Psoriasis Therapies
10个月前
已完结
A polymorphism in the gene encoding the Fc IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis
11个月前
已完结
A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping
11个月前
已完结
Influence of variants of Fc receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor therapy in rheumatoid arthritis
11个月前
已完结
皖公网安备34019202002308
